glp 1 development history GLP-1-based therapies for diabetes, obesity and beyond Historical timeline of GLP-1 biology,

L., Pipingas, A., Macpherson, H., Wesnes, K., Ou, R., Hare, D., de Haan, J., Head, G., Lansjoen, P., Langsjoen, A., Tan, B., Pase, M

Evidence Strength Grade C) Guideline Statement 13 Clinicians should counsel patients with Peyronie's disease prior to beginning treatment with intralesional verapamil about potential adverse events, including penile bruising, dizziness, nausea, and pain at the injection site

However, these medications may be covered under Medicare for type 2 diabetes, cardiovascular risk reduction (Wegovy), or obstructive sleep apnea (Zepbound)

Diabetes Obes Metab 26(Suppl 4):1627 Xiang J, Qin L, Zhong J, Xia N, Liang Y (2023) GLP-1RA liraglutide and semaglutide improves Obesity-Induced muscle atrophy via SIRT1 pathway

doi: 10.1002/psc.70001